EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

Primary Systemic Therapy ◽

Mesenchymal Transition ◽

Cell Phenotypes

Abstract P4-01-10: Predictive impact of circulating tumor cells with an epithelial-to-mesenchymal transition phenotype in patients with primary breast cancer treated with primary systemic therapy

10.1158/1538-7445.sabcs14-p4-01-10 ◽

2015 ◽

Author(s):

Fanny Le Du ◽

Dzifa Y Duose ◽

Elisha J Dettman ◽

Jackson A Summer ◽

Mariana Chavez-MacGregor ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Systemic Therapy ◽

Primary Breast Cancer ◽

Primary Systemic Therapy ◽

Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients

Anticancer Research ◽

10.21873/anticanres.14817 ◽

2021 ◽

Vol 41 (2) ◽

pp. 661-670

Author(s):

MARIA A. PAPADAKI ◽

DESPOINA AGGOURAKI ◽

ELENI-KYRIAKI VETSIKA ◽

NIKOLAOS XENIDIS ◽

GALAKTEA KALLERGI ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

British Journal of Cancer ◽

10.1038/bjc.2011.159 ◽

2011 ◽

Vol 104 (11) ◽

pp. 1730-1738 ◽

Cited By ~ 109

Author(s):

H E Lee ◽

J H Kim ◽

Y J Kim ◽

S Y Choi ◽

S-W Kim ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Prognostic Factor ◽

Cancer Stem Cell ◽

Cell Population ◽

Systemic Therapy ◽

Stem Cell Population ◽

Primary Systemic Therapy ◽

Poor Prognostic Factor ◽

Cancer Stem Cell Population

Abstract P3-02-09: Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Primary Breast Cancer Patients with Circulating Tumor Cells

10.1158/0008-5472.sabcs10-p3-02-09 ◽

2010 ◽

Author(s):

T Fehm ◽

O Hoffmann ◽

P Wagner ◽

C Goldnau ◽

H Neubauer ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Primary Breast Cancer ◽

Epithelial Mesenchymal Transition ◽

Breast Cancer Patients ◽

Abstract 2387: Analysis of the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with breast cancer

10.1158/1538-7445.am2012-2387 ◽

2012 ◽

Cited By ~ 1

Author(s):

Maria A. Papadaki ◽

Galaktia Kallergi ◽

Sofia Agelaki ◽

Hara Polioudaki ◽

Dimitrios Mavroudis ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Circulating Tumor Cells With Epithelial–to–mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer

Anticancer Research ◽

10.21873/anticanres.13290 ◽

2019 ◽

Vol 39 (4) ◽

pp. 1829-1837 ◽

Cited By ~ 15

Author(s):

MICHAL MEGO ◽

MARIAN KARABA ◽

GABRIEL MINARIK ◽

JURAJ BENCA ◽

JURISOVA SILVIA ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Primary Breast Cancer ◽

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144

Experimental Cell Research ◽

10.1016/j.yexcr.2012.11.004 ◽

2013 ◽

Vol 319 (3) ◽

pp. 12-22 ◽

Cited By ~ 47

Author(s):

Idoia G. Zubeldia ◽

Anne-Marie Bleau ◽

Miriam Redrado ◽

Diego Serrano ◽

Alice Agliano ◽

...

Keyword(s):

Stem Cell ◽

Liver Metastasis ◽

Cancer Stem Cell ◽

The Novel ◽

Mesenchymal Transition ◽

Cell Phenotypes

Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer

BMC Cancer ◽

10.1186/s12885-015-1548-7 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 23

Author(s):

M. Mego ◽

Z. Cierna ◽

P. Janega ◽

M. Karaba ◽

G. Minarik ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Early Breast Cancer ◽

Abstract P2-01-07: Effect of first-line chemotherapy in the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with metastatic breast cancer.

10.1158/0008-5472.sabcs12-p2-01-07 ◽

2012 ◽

Author(s):

MA Papadaki ◽

G Kallergi ◽

D Mavroudis ◽

V Georgoulias ◽

PA Theodoropoulos ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Metastatic Breast ◽

First Line ◽

Mesenchymal Transition ◽

Line Chemotherapy

Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo

BMC Cancer ◽

10.1186/s12885-019-5811-1 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 4

Author(s):

Jia-Hong Chen ◽

Wen-Chien Huang ◽

Oluwaseun Adebayo Bamodu ◽

Peter Mu-Hsin Chang ◽

Tsu-Yi Chao ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast Cancer ◽

Cancer Stem Cell ◽

Metastatic Breast ◽

Mesenchymal Transition ◽

Monospecific Antibody